MedTrace Logo

Autoimmune Hepatitis in Pediatric Patients

NCT04247490 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2020-01-30

No results posted yet for this study

Summary

Autoimmune hepatitis (AIH) is an immune-mediated and inflammatory liver disorder. It is currently divided into types 1 and 2, differentiated and defined by the presence of specific autoantibodies. The objectives are to describe the prevalence and incidence of type 1 and 2 autoimmune hepatitis and to analyze the clinics, biochemical and histopathological profiles at diagnosis and follow-up, initial therapy, response to therapy and long-term follow-up in three Italian centers of patients with type 1 and type 2 AIH.

Conditions

  • Autoimmune Hepatitis

Interventions

DIAGNOSTIC_TEST

pediatric AIH

pediatric patients with clinical, laboratory (transaminase and IgG increase), instrumental (ultrasound, liver biopsy) characteristics

Sponsors & Collaborators

  • University Hospital of Ferrara

    lead OTHER

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-17
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04247490 on ClinicalTrials.gov